Background
==========

The phenotypic and biochemical changes occurring in response to exercise training have been extensively studied in humans and mammals, the results mainly being of a descriptive nature. The adaptive response to training is dependent on variations in exercise-induced changes in muscle load, energy requirements and calcium flux. Endurance training results in increased aerobic capacity \[[@B1]\], mitochondrial biogenesis \[[@B2]\] and a shift from carbohydrate to fat metabolism \[[@B3]\] whereas resistance training promotes protein synthesis \[[@B4],[@B5]\], muscle hypertrophy \[[@B6]\] and a switch from slow to fast twitch muscle. Numerous equine studies have also confirmed an increase in VO~2max~and an increase in oxidative enzyme activity \[[@B7]-[@B12]\] following endurance training. An increase in type II and a concurrent decrease in type IIX fibres is observed in Thoroughbreds in response to high intensity training \[[@B13],[@B14]\]. Also, anerobic capacity and speed and strength have been observed to increase following short duration high intensity (\~100-150% VO~2max~) exercise \[[@B14]-[@B16]\].

In contrast, much less is known regarding the transcriptional reprogramming underlying the highly specific adaptive responses to endurance and resistance exercise. Exercise studies using human subjects and animal models have demonstrated that changes in the expression of a wide range of mRNA transcripts play a major role in the recovery of muscle following exercise with the expression levels of most genes returning to baseline within 24 hours \[[@B17]-[@B23]\]. However, it appears that repeated bouts of exercise lead to new basal levels of gene expression in resting muscle. Higher levels of mitochondrial genes and genes involved in energy metabolism were observed in endurance trained athletes compared to sedentary subjects \[[@B24]\]. Further evidence for a new steady state level of exercise related genes comes from a recent study in which differential levels of gene expression were observed in resting skeletal muscle from sedentary, endurance trained and resistance trained subjects. However the use of intra rather than inter-individual genetic comparisons as well as different training stimuli may have contributed to the observed differences in gene expression between the groups. The majority of differentially expressed genes were common to both trained states \[[@B25]\]. A surprisingly small number of genes were differentially expressed between endurance trained and resistance trained subjects given the very different phenotypic changes and distinct signalling pathways \[[@B26],[@B27]\] associated with each form of exercise. Studies have indicated that concurrent endurance and resistance training results in impaired strength development and aerobic capacity when compared to a training regime with a single exercise mode \[[@B28]-[@B31]\] a phenomenon described as the interference effect. However, conflicting studies have found little or no effect of a combined training regime on strength and aerobic capacity \[[@B32]-[@B35]\]. The aim of this study was to investigate the global transcriptional response in skeletal muscle to a training regime combining endurance and high intensity sprint exercise in Thoroughbred racehorses. We hypothesise that following training differential expression of genes related to both aerobic capacity and muscle hypertrophy will be observed reflecting the dual nature of the training regime.

The Thoroughbred is a novel and valuable model for identifying molecular mechanisms basic to both endurance and resistance adaptive responses. Competitive horse racing dates to 4500 BC and Thoroughbreds have been bred for speed and stamina since the 1700 s. This intense selection has resulted in a highly adapted athlete \[[@B36]\]. Thoroughbreds have a very high aerobic capacity or maximal oxygen uptake (VO~2max~) \[[@B37]\] relative to their body mass. For instance, VO~2max~can reach 180-200 mL O~2~/min/kg, approximately 2.5 times higher than other species of similar size\[[@B38]\]. This is achieved through a large lung volume, high cardiac output, high haemoglobin concentration, high muscle mitochondrial volume and a high skeletal muscle mass \[[@B38]-[@B44]\]. During intense exercise such as under racing conditions a Thoroughbred may increase its metabolic rate from basal levels by up to 60-fold \[[@B45]\]. Furthermore, the Thoroughbred has a very high skeletal muscle mass comprising over 55% of total body mass \[[@B46]\].

A Thoroughbred racehorse trained for flat racing undergoes a training regime comprising intermittent days of sprint exercise to promote increased muscle mass among periods of prolonged exercise at a slower pace to enhance aerobic capacity. In a previous study we detected molecular signatures of both endurance and resistance exercise in untrained Thoroughbred skeletal muscle following a single bout of exhaustive exercise \[[@B47]\]. A further advantage of using Thoroughbreds as an exercise model is that inter-individual comparisons can be made between subjects that come from a similar background (genetic and environmental) and have undergone a similar exercise regime with relatively little variation in management. Variations in genetic and environmental conditions cannot be controlled to the same extent in human subjects.

To-date the main approach to investigating global transcriptional changes has been the use of gene expression microarray platforms \[[@B47]-[@B49]\]. In this study we have used digital gene expression (DGE, Illumina) profiling to characterize the assembly of genes expressed in equine skeletal muscle and to identify the subset of genes that were differentially expressed following a ten month period of exercise training. DGE is a recently developed alternative to microarray gene expression profiling \[[@B50]-[@B52]\]. The DGE method involves the generation of a cDNA library with a 17 bp tag generated by restriction digestions for each mRNA transcript. The tags are directly sequenced using the Illumina Genome Analyzer creating millions of short reads. In contrast to microarray technology which is limited to the hybridisation of cDNA to probes printed on the array platform, DGE is not dependent on currently available genome sequence and thus provides a global, hypothesis-free quantitative analysis of the transcriptome. The technique is conceptually similar to serial analysis of gene expression (SAGE) \[[@B53]\] but substantially less expensive, more general and capable of delivering more information.

Using this technique we investigated 1) the overrepresentation of functional groups in skeletal muscle relative to the entire genome, 2) the genes differentially expressed in trained relative to untrained skeletal muscle, and 3) the overrepresentation of functional groups in genes differentially expressed following training in skeletal muscle.

Results and discussion
======================

Representation of genes by DGE tags
-----------------------------------

A limitation of genome wide gene expression analysis using DGE is that it is not possible to evaluate the expression of genes that do not contain a *NlaIII*restriction site and in some cases there is ambiguity regarding the tag-gene matches as a single tag may match to two or more genes. 91% (*n*= 22,996) of equine genes with Ensembl gene IDs (*n*= 25,180) have a *NlaIII*restriction site but 13% of these are not unique; therefore, 78% (*n*= 19,271) of currently annotated equine genes are quantifiable using DGE.

As poor quality sequence was obtained for one of the samples just 13 samples were used for analysis. Of the 13 samples successfully sequenced a total of 183 million raw reads were generated. Of these 119 million reads passed the Illumina pipeline quality filters. These 119 million usable reads consisted of 17.6 million unique tags. 66% of the usable reads mapped to the horse genome, 30% of the usable reads mapped to the predicted Ensembl gene restriction sites and 36% to the genomic regions.

The intragenic reads may represent regulatory non-coding RNAs or novel genes. However, more likely is the explanation that these tags are a combination of segments of genes that were excluded from the current annotation (or assembly) of the equine genome; an observation which has been previously reported \[[@B54]\] as well as tags containing sequencing errors. We expect that as the annotation of the horse transcriptome improves that most of the genomic tags we have sequenced will be reassigned to genic tags. In particular we believe that a *de novo*transcriptome assembly approach (using longer sequencing reads) of the equine muscle transcriptome would enable us to more accurately allocate tags to the correct gene models. In the absence of an accurate muscle transcriptome we believe that the Ensembl horse transcriptome, which is predominantly automatically generated and infers much of the information about gene models by homology from better annotated organisms, represents the best available option for DGE tag mapping.

The reasons that reads may not match a genomic location include ambiguous reads (same sequence tag present in more than one genomic location), reads overlapping an unannotated exon boundary, sequencing errors or single nucleotide variants present in the tag. Due to the short nature of the reads used in DGE compared to other sequencing protocols it is problematic to correct for SNPs or sequencing errors by allowing mismatched bases. Other protocols (*e.g*. RNAseq), which generate longer tags, can overcome this limitation but they introduce new problems, the most important of which is multiple tags per transcript and a bias towards highly expressed long transcripts \[[@B55]\]. The intragenic reads may represent regulatory non-coding RNAs or novel genes. However, more likely is the explanation that these tags represent segments of genes that were excluded from the current annotation (or assembly) of the equine genome; an observation which has been previously reported \[[@B54]\].

Only the 20% of reads that unambiguously matched Ensembl genes were used for further analysis. These represented 5,068 unique genes, \~25% of annotated equine genes. As some genes were represented by multiple different transcripts these were summed to calculate the total number of reads per gene. Highly expressed genes where \> 50,000 tags per million (TPM) were detected made up 39% of all annotated reads. However, the majority of unique genes were expressed at low levels (*i.e*. 2,200 genes, \< 40 TPM) and there was an inverse relationship between the level of gene expression and the number of genes expressed (Figure [1](#F1){ref-type="fig"}).

![**Relationship between the number of genes expressed and mRNA abundance**. a - Number of genes compared to tags per million per gene. b - The % of the total number of reads compared to the tags per million per gene.](1471-2164-11-398-1){#F1}

Functional annotation of muscle transcriptome
---------------------------------------------

Using the online tool DAVID, 448 gene ontology groups and 14 KEGG pathways were observed to be significantly (FDR = 0.05) overrepresented in skeletal muscle relative to the entire genome. There was a substantial overlap of genes within these functional groups resulting in the overrepresentation of a large number of functionally similar gene ontology groups. Therefore only the highly significant groups are shown in Table [1](#T1){ref-type="table"}. The overrepresentation of mitochondrial genes, and genes involved in muscle contraction and metabolism concurs with current SAGE data \[[@B56]\]. However, an overrepresentation of genes related to RNA processing, the stress response and proteolysis has not, to our knowledge, previously been reported in the muscle transcriptome. DGE is much more sensitive to the detection of low level transcripts than SAGE and consequently provides greater coverage of the muscle transcriptome. When functional analysis of only the highly expressed genes (those comprising \> 0.05% of annotated muscle transcriptome) was performed, the novel overrepresented functional groups were not identified. This indicates that these are comprised of genes expressed at relatively low levels. Furthermore, functional groups involved in muscle contraction and aerobic respiration were more significantly overrepresented among the highly expressed genes (Table [1](#T1){ref-type="table"}).

###### 

Functional groups of genes identified in the equine skeletal muscle transcriptome.

                                                   All genes   High abundance genes                                         
  --------------- -------------------------------- ----------- ---------------------- ---------------- ----------- -------- ----------------
  **GO ID**       **Term**                         **Count**   **FC**                 **Adj P**        **Count**   **FC**   **Adj P**
                                                                                                                            
  GO BP:0008152   metabolic process                2468        1.19                   8.17 × 10^-55^   131         1.2      4.13 × 10^-08^
  GO MF:0005515   protein binding                  2122        1.35                   4.53 × 10^-90^   105         1.3      2.88 × 10^-12^
  GO CC:0043234   protein complex                  713         1.57                   2.75 × 10^-43^   68          2.9      1.32 × 10^-15^
  GO CC:0005739   mitochondrion                    407         1.97                   5.63 × 10^-49^   53          4.9      3.71 × 10^-23^
  GO BP:0006936   *muscle contraction*             73          1.94                   1.78 × 10^-07^   33          8.7      3.98 × 10^-17^
  hsa00190        *Oxidative phosphorylation*      56          1.55                   0.006            32          9.5      4.47 × 10^-18^
  GO MF:0003723   RNA binding                      289         1.76                   3.84 × 10^-23^   27          3.3      3.78 × 10^-06^
  GO MF:0009055   *electron carrier activity*      94          1.81                   1.47 × 10^-07^   24          9.4      1.43 × 10^-11^
  GO CC:0043292   *contractile fibre*              50          3.37                   3.19 × 10^-17^   23          29.9     5.32 × 10^-18^
  GO CC:0005840   *ribosome*                       93          1.32                   1.63 × 10^-02^   21          5.8      9.29 × 10^-09^
  GO MF:0005524   ATP binding                      434         1.28                   1.71 × 10^-07^   20          1.2      NS
  GO BP:0006950   response to stress               337         1.39                   9.17 × 10^-10^   19          1.5      NS
  GO CC:0044428   nuclear part                     429         1.88                   9.51 × 10^-46^   10          0.8      NS
  GO BP:0006457   protein folding                  132         2.12                   5.64 × 10^-18^   10          3.1      0.007
  GO BP:0015031   protein transport                290         1.85                   5.91 × 10^-28^   7           0.9      NS
  GO MF:0045182   translation regulator activity   76          2.40                   9.13 × 10^-13^   5           3.2      NS
  GO BP:0006396   RNA processing                   195         1.90                   8.21 × 10^-20^   4           0.8      NS
  GO MF:0008134   transcription factor binding     153         1.67                   1.89 × 10^-09^   4           0.9      NS
  hsa00620        Pyruvate metabolism              27          2.28                   3.30 × 10^-04^   4           3.6      NS
  hsa00020        Citrate cycle (TCA cycle)        20          2.36                   0.003            4           5.1      NS
  hsa04120        Ubiquitin mediated proteolysis   55          1.49                   0.016            2           0.6      NS
                                                                                                                            
  hsa00071        Fatty acid metabolism            24          1.89                   0.017            2           1.7      NS
                                                                                                                            
  GO CC:0005681   spliceosome                      78          2.71                   2.04 × 10^-18^   1           0.7      NS
  hsa03050        Proteasome                       21          3.38                   2.28 × 10^-07^   1           1.7      NS

GO categories and KEGG pathways overrepresented among genes expressed in equine skeletal muscle compared to all annotated equine genes. Terms in italics are more significantly overrepresented among the high abundance genes. High abundance genes are defined as those comprising \> 0.05% of annotated muscle transcriptome. FC - fold change; Adj P - adjusted *P*value using the Benjamini and Hochberg method.

A list of the most abundant genes (those comprising \>0.5% of annotated muscle transcriptome) is presented in Table [2](#T2){ref-type="table"}. Just 28 genes contribute to over 50% of the annotated mRNA in equine skeletal muscle and are principally involved in muscle contraction and energy metabolism. Creatine kinase muscle (*CKM*) was the most abundantly expressed gene in equine skeletal muscle representing 6.9% of the annotated transcriptome and creatine kinase, mitochondrial 2, (*CKMT2*), was ranked 20^th^among the most abundantly expressed genes, making up 0.8% of the transcriptome. Human studies using SAGE have indicated that *CKM*mRNA makes up \~1% of the human skeletal muscle transcriptome and *CKMT2*did not feature in a list of the 54 most abundantly expressed genes \[[@B56]\]. The very high levels of both isoforms of creatine kinase in equine muscle compared to humans is indicative of the highly adapted athletic capacity of Thoroughbred horses as creatine kinases play a crucial role as an energy store in tissues with fluctuating energy demands. CKM is utilised during anaerobic respiration while CKMT2 is tightly coupled to oxidative phosphorylation \[[@B57]-[@B60]\]. The importance of CKM in athletic adaptation in the horse is further supported by the identification of a novel SNP in the *CKM*gene that, in a preliminary study, has been observed to be associated with racing performance \[[@B61]\]. The third most highly expressed gene in equine skeletal muscle, actin, alpha 1, skeletal muscle (*ACTA1*) has also been implicated as a candidate athletic performance gene following a genome scan for positive selection in Thoroughbred horses \[[@B62]\].

###### 

Highly abundant transcripts in equine skeletal muscle

  Gene symbol   Gene name                                                                                     Total reads   \% All   Cumulative %   Average no. reads pre-training   \% All   Average no. reads post training   \% All
  ------------- --------------------------------------------------------------------------------------------- ------------- -------- -------------- -------------------------------- -------- --------------------------------- --------
  *CKM*         Creatine kinase, muscle                                                                       236,942       6.9      6.9            18,642                           6.7      17,870                            7.1
  *MYL1*        Myosin, light polypeptide 1, alkali; skeletal, fast                                           203,634       5.9      12.8           17,454                           6.2      14,130                            5.6
  *ACTA1*       Actin, alpha 1, skeletal muscle                                                               147,884       4.3      17.1           15,065                           5.4      8,214                             3.3
  *TNNC2*       Troponin C type 2 (fast)                                                                      147,779       4.3      21.4           12,128                           4.3      10,716                            4.2
  *ALDOA*       Aldolase A, fructose-bisphosphate                                                             118,636       3.4      24.8           9,506                            3.4      8,800                             3.5
  *TTN*         Titin                                                                                         116,385       3.4      28.2           9,919                            3.5      8,125                             3.2
  *MYLPF*       Myosin light chain, phosphorylatable, fast skeletal muscle                                    97,094        2.8      31.0           7,426                            2.7      7,506                             3.0
  *MYH1*        Myosin, heavy polypeptide 1, skeletal muscle, adult                                           91,271        2.7      33.7           8,611                            3.1      5,658                             2.2
  *TPM2*        Tropomyosin 2 (beta)                                                                          73,395        2.1      35.8           6,240                            2.2      5,136                             2.0
  *ATP2A1*      ATPase, Ca++ transporting, cardiac muscle, fast twitch 1                                      59,889        1.7      37.6           5,516                            2.0      3,827                             1.5
  *RPLP1P4*     Ribosomal protein, large, P1 pseudogene 4                                                     55,290        1.6      39.2           4,340                            1.6      4,178                             1.7
  *ENO3*        Enolase 3 (beta, muscle)                                                                      40,827        1.2      40.4           3,143                            1.1      3,138                             1.2
  *LOC440359*   Similar to cold shock domain protein A short isoform                                          36,681        1.1      41.4           2,877                            1.0      2,774                             1.1
  *ATP5O*       ATP synthase, H+ transporting, mitochondrial f1 complex, o subunit                            34,234        1.0      42.4           2,212                            0.8      2,994                             1.2
  *MYOZ1*       MYOZENIN 1                                                                                    32,638        0.9      43.4           2,449                            0.9      2,564                             1.0
  *PYGM*        Phosphorylase, glycogen; muscle                                                               31,710        0.9      44.3           2,895                            1.0      2,048                             0.8
  *TPM1*        Tropomyosin 1 (alpha)                                                                         30,823        0.9      45.2           2,820                            1.0      1,986                             0.8
  *MYBPC2*      Myosin binding protein C, fast type                                                           28,386        0.8      46.0           2,409                            0.9      1,990                             0.8
  *TNNT3*       Troponin t type 3 (skeletal, fast)                                                            27,469        0.8      46.8           1,960                            0.7      2,244                             0.9
  *CKMT2*       Creatine kinase, mitochondrial 2 (sarcomeric)                                                 27,394        0.8      47.6           1,622                            0.6      2,523                             1.0
  *TNNI2*       Troponin I type 2 (skeletal, fast)                                                            25,005        0.7      48.3           1,674                            0.6      2,138                             0.8
  *PGK1*        Phosphoglycerate kinase 1                                                                     24,378        0.7      49.0           2,005                            0.7      1,764                             0.7
  *RPL30*       Ribosomal protein L30                                                                         23,575        0.7      49.7           2,162                            0.8      1,515                             0.6
  *NDUFAB1*     NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8 kDa                            22,285        0.6      50.4           1,570                            0.6      1,838                             0.7
  *SLC25A4*     Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4   21,881        0.6      51.0           1,270                            0.5      2,037                             0.8
  *ACTN3*       Actinin, alpha 3                                                                              21,097        0.6      51.6           2,042                            0.7      1,264                             0.5
  *PGAM2*       Phosphoglycerate mutase 2 (muscle)                                                            21,059        0.6      52.2           1,736                            0.6      1,521                             0.6
  *RPS13*       Ribosomal protein S13                                                                         19,063        0.6      52.8           1,610                            0.6      1,343                             0.5

Differential gene expression following training
-----------------------------------------------

Following correction for multiple testing, a total of 92 transcripts were significantly (FDR = 0.05) differentially expressed in the skeletal muscle transcriptome following a ten month period of training: nineteen transcripts showed increased expression (+0.72-fold to +29.3-fold), and 73 displayed decreased expression (-0.43-fold to -4.2-fold). Twenty of the differentially expressed transcripts lay within annotated genes, 54 transcripts were located \< 5 kb up or downstream of annotated genes and for 18 transcripts no annotated genes were located within 5 kb. The transcripts located in the vicinity of equine genes may represent regulatory regions of the genes and more in-depth analysis and annotation of the recently sequenced equine genome may lead to a reassessment of the boundaries of many currently annotated genes \[[@B63]\]. The uncharacterised transcripts that were not in the region of any known equine gene may represent novel equine exercise related genes or non-protein coding regulatory mRNAs. The differentially expressed transcripts, including those located within 5 kb of a known gene, and the associated gene names are listed in Table [3](#T3){ref-type="table"} and Table [4](#T4){ref-type="table"}.

###### 

Genes significantly up-regulated post-training compared to pre-training levels

  Tag                 Gene symbol     Gene name                                                                  FC      Adj *P*
  ------------------- --------------- -------------------------------------------------------------------------- ------- ---------
  gctgctctgcagtctga   *ACADVL*        Acyl-Coenzyme A dehydrogenase, very long chain                             0.72    0.037
  gaataattgaagactgg   *ACTR3B*        Arp3 Actin-Related Protein 3 Homolog B                                     2.37    0.041
  gcgtccttgaggtccgg   *C14orf153\**   Chromosome 14 open reading frame 153                                       1.14    0.049
  ctgtttttctgtttttt   *CUL3\**        Cullin 3                                                                   1.43    0.004
  tgataccaatattcagt   *FBXO32\**      F-box protein 32                                                           1.17    0.009
  cagaaagagcagggaag   *GOT1\**        Glutamic-oxaloacetic transaminase 1, soluble                               1.46    0.035
  tggatgtgtggctatgg   *GRHPR*         Glyoxylate Reductase/Hydroxypyruvate Reductase                             1.45    0.043
  ggacccatgaaggacca   *IGFN1\**       Immunoglobulin-like and fibronectin type III domain-containing protein 1   2.03    0.019
  tggttctgtttgttttg   *KIAA1303\**    P150 target of rapamycin (TOR)-scaffold protein                            2.70    0.049
  gagtgcagcctttcacc   *MRPS21*        28 S ribosomal protein S21, mitochondrial                                  3.24    0.024
  accagagagatgaatgt   *MRPS21*        28 S ribosomal protein S21, mitochondrial                                  1.76    0.032
  tgttgaagcgatgcagt   *PER2\**        Period homolog 2                                                           29.26   0.004
  tgttggtaagtagatcg   *PER3\**        Period homolog 3 (Drosophila)                                              1.05    0.047
  tggctgtatggggaggc   *SLC25A29\**    Solute carrier family 25 member 29                                         1.32    0.013
  gccttctgcacccagaa   *TNNT3\**       Troponin T Type 3 (Skeletal, Fast)                                         1.55    0.002
  ttaaatatacttggaag   *ZAK\**         Sterile alpha motif and leucine zipper containing kinase AZK               2.08    0.023

An asterisk (\*) indicates that the tag lay within 5 kb of the gene. FC - fold change; Adj P - adjusted *P*value using the Benjamini and Hochberg method.

###### 

Genes significantly down-regulated post-training compared to pre-training levels

  Tag                 Gene Symbol   Gene Name                                                           FC      Adj *P*
  ------------------- ------------- ------------------------------------------------------------------- ------- --------------
  acccgagagacagccga   *ACTN3*       actinin, alpha 3                                                    -0.97   0.029
  acacagttagttaattt   *AHCYL2\**    Putative adenosylhomocysteinase 3                                   -1.39   0.006
  acacagttagttaattt   *AHCYL2\**    Putative adenosylhomocysteinase 3                                   -1.39   0.006
  taattttatttttttta   *ANKHD1\**    Ankyrin repeat and KH domain containing 1                           -2.30   0.043
  ttttccctcacatcttc   *APOOL\**     Apolipoprotein O-like                                               -0.54   0.003
  cttagtgtgtatatctc   *ATP2B1*      ATPase, Ca++ transporting, plasma membrane 1                        -0.62   0.041
  atcattattttaccttt   *BCL6\**      B-cell CLL/lymphoma 6                                               -3.09   0.011
  acggttttccccagatc   *C1orf51\**   Chromosome 1 open reading frame 51                                  -1.61   0.035
  cactggccaaaagattt   *C21orf7*     Chromosome 21 open reading frame 7                                  -3.08   0.035
  ccactaccctcttactc   *CALM3\**     Calmodulin3                                                         -1.46   0.009
  acagacacttggctaaa   *CALM3\**     Calmodulin3                                                         -0.83   0.043
  aacagaatcaaggagct   *CCNDBP1*     Cyclin-D1-binding protein 1                                         -0.81   0.035
  gaaaacagtagctaaag   *DAG1*        dystroglycan 1                                                      -1.49   0.022
  ctcaacagcaacatcaa   *EIF3F*       Eukaryotic translation initiation factor 3, subunit F               -0.52   0.002
  tccagcctcaaagcatt   *FBXL17\**    F-Box And Leucine-Rich Repeat Protein 17                            -0.52   0.002
  aactgtagtgctttaaa   *GATM*        Glycine Amidinotransferase                                          -1.35   0.035
  taggttttacctccatt   *GATM\**      Glycine Amidinotransferase                                          -1.35   0.001
  ctggaacaggggcgaac   *GLUL\**      Glutamate-ammonia ligase                                            -3.94   0.007
  cccatcatccccttcct   *GPSN2*       GLYCOPROTEIN, SYNAPTIC 2                                            -1.06   0.004
  aagtcccaccccaatat   *GSTM5\**     Glutathione S-transferase M5                                        -1.1    0.004
  tccacccataagcagat   *HOXC9\**     Homeobox protein Hox-C9                                             -1.04   0.038
  ggactgtctttattttt   *IGFBP5\**    Insulin-like growth factor binding protein-5                        -2.32   0.001
  gtaaccctacacagtca   *IGFBP5\**    Insulin-like growth factor binding protein-5                        -2.12   0.038
  cccagaaagacatttgt   *IRF2BP2\**   Interferon regulatory factor 2 binding protein 2                    -1.57   0.001
  caaaaggctctcctaat   *KCMF1*       potassium channel modulatory factor 1                               -0.81   0.048
  tttccattcaacaaaaa   *KPNA1\**     Karyopherin alpha 1                                                 -1.8    0.006
  aattactctttcactgt   *KPNA3\**     Karyopherin alpha 3                                                 -1.55   0.043
  cttttcacacacaaaac   *LRRFIP1\**   Leucine Rich Repeat                                                 -0.95   4.1 × 10^-5^
  ttaagtgccattactac   *MAP3K4*      Mitogen-activated protein kinase kinase kinase 4                    -0.85   0.048
  ccccaccctactcccac   *MLEC\**      Malectin                                                            -1.13   0.017
  tatgacagaaaagcaac   *MSTN\**      Myostatin                                                           -2.56   0.002
  atgactgtataatgtga   *MSTN\**      Myostatin                                                           -2.55   0.008
  gttcctaaataaataat   *MSTN\**      Myostatin                                                           -4.2    0.004
  ctgctgagcggcctctc   *MYLK2*       Myosin Light Chain Kinase 2, Skeletal Muscle                        -1.94   0.034
  gctcattaaagaacaaa   *MYO9A\**     Myosin Ixa                                                          -1.03   0.043
  ctatcttttccttttct   *NAT12\**     N-acetyltransferase MAK3 homolog                                    -0.68   0.002
  attgtttaaatatcact   *NEDD4\**     Neural precursor cell expressed, developmentally down-regulated 4   -0.97   0.012
  aaatcccaccctcccct   *NLN\**       Neurolysin                                                          -1.02   0.008
  tccagctttctattctt   *PALLD\**     Palladin, cytoskeletal associated protein                           -1.06   0.039
  cttctttccccacctcc   *PCBP4*       Poly(rC) binding protein 4                                          -0.82   0.004
  taattgcagtttactat   *GNPNAT1\**   Similar to glucosamine-phosphate N-acetyltransferase 1              -1.23   0.006
  ctctagaacatttacct   *PTDSS1\**    Phosphatidylserine synthase 1                                       -0.62   0.003
  agagtcaatataaaggt   *PTPLA\**     Protein Tyrosine Phosphatase-Like                                   -2.07   0.01
  aaatctaaagttaaata   *RAB33B\**    RAB33B, member RAS oncogene family                                  -1.24   0.04
  cagccctgggggcctac   *RYK*         Ryk Receptor-Like Tyrosine Kinase                                   -0.94   0.005
  attcccatttctagtaa   *SEPT7\**     Transcribed locus                                                   -0.72   0.018
  tgaggacaaagctcagg   *SLC10A2\**   Solute carrier family 10                                            -4.11   0.001
  ccttcaactcaacaaat   *SNAP29\**    Synaptosomal-associated protein, 29 kDa                             -0.43   0.009
  gtattgtaagatattaa   *SNORA24\**   Small nucleolar RNA SNORA24                                         -0.89   0.037
  aagcaagaaataaattt   *TET1\**      Tet oncogene 1                                                      -1.4    0.029
  atgcagagcaccacaga   *TLE1*        transducin-like enhancer of split 1                                 -1.58   2.0 × 10^-5^
  actgacatatgtaaaga   *TOR3A\**     torsin family 3, member A                                           -1.49   0.022
  tgcctatcacctgccgg   *TPD52\**     Tumor protein D52                                                   -0.68   0.005
  tcctttcagtcttcaca   *TSPAN3*      Tetraspanin 3                                                       -0.58   0.04
  ctttgtgacttccaagt   *ULK2\**      Unc-51-like kinase 2                                                -0.72   0.018
  aaaccatatttcttccc   *VCL\**       Vinculin                                                            -1.13   0.005
  cccaggcccgtccctgc   *ZC3H3\**     Zinc finger CCCH-type containing 3                                  -1.28   0.035
  aagtctaacttccattt   *ZNF704\**    Zinc finger protein 704                                             -0.93   0.013
  ttagtttcttttcttta   *ZWINT\**     ZW10 interactor                                                     -1.21   1.1 × 10^-4^

An asterisk (\*) indicates that the tag lay within 5 kb of the gene. FC - fold change; Adj P - adjusted *P*value using the Benjamini and Hochberg method.

Genes with higher post-training basal mRNA levels included those involved in the mitochondria, ubiquitination and circadian rhythm regulation, whereas genes with significantly reduced mRNA were mainly associated with cytoskeletal structure and the control of growth and development.

Functional profiling of differentially expressed genes
------------------------------------------------------

Significantly up and down-regulated blocks of functionally related genes were identified by performing a gene enrichment test (FatiScan) for all expressed genes ranked according to differential expression following training. Among the up-regulated genes we identified 275 significantly (FDR \< 0.05) overrepresented GO terms and 13 KEGG pathways. Among the down-regulated genes we identified 207 significantly (FDR \< 0.05) overrepresented GO terms and five KEGG pathways. Subsets of the functional groups are shown in Table [5](#T5){ref-type="table"} and Table [6](#T6){ref-type="table"}, and were chosen to include all significant (FDR\<0.05) KEGG pathways and all highly significantly (FDR \< 0.0001) overrepresented functional groups satisfying GO \> level 6 and for which at least six genes were identified.

###### 

Gene ontology categories with significantly increased expression post-training compared to pre-training levels

  GO ID         GO Term                                                            *P*
  ------------- ------------------------------------------------------------------ ----------------
  BP:0009060    aerobic respiration                                                1.89 × 10^-16^
  BP:0046356    acetyl-CoA catabolic process                                       2.28 × 10^-16^
  BP:0006099    tricarboxylic acid cycle                                           5.83 × 10^-16^
  BP:0006100    tricarboxylic acid cycle intermediate metabolic process            5.92 × 10^-10^
  BP:0019395    fatty acid oxidation                                               4.65 × 10^-08^
  BP:0006119    oxidative phosphorylation                                          3.69 × 10^-06^
  BP:0006956    complement activation                                              4.07 × 10^-06^
  BP:0002455    humoral immune response mediated by circulating immunoglobulin     4.07 × 10^-06^
  BP:0002253    activation of immune response                                      5.31 × 10^-06^
  BP:0006635    fatty acid beta-oxidation                                          6.70 × 10^-06^
  BP:0002541    activation of plasma proteins during acute inflammatory response   8.46 × 10^-06^
  BP:0050778    positive regulation of immune response                             8.46 × 10^-06^
  BP:0006631    fatty acid metabolic process                                       7.12 × 10^-05^
  CC:0005739    mitochondrion                                                      1.04 × 10^-41^
  CC:0043231    intracellular membrane-bound organelle                             8.17 × 10^-21^
  CC:0019866    organelle inner membrane                                           2.16 × 10^-19^
  CC:0044429    mitochondrial part                                                 1.04 × 10^-16^
  CC:0044444    cytoplasmic part                                                   6.14 × 10^-16^
  CC:0031967    organelle envelope                                                 1.07 × 10^-08^
  CC:0031090    organelle membrane                                                 2.25 × 10^-05^
  CC:0000793    condensed chromosome                                               5.40 × 10^-05^
  CC:0005840    ribosome                                                           7.74 × 10^-05^
                                                                                   
  **KEGG ID**   **KEGG pathway**                                                   
                                                                                   
  hsa04510      Complement and coagulation cascades                                5.61 × 10^-06^
  has00750      Vitamin B6 metabolism                                              1.21 × 10^-04^
  hsa00790      Folate biosynthesis                                                1.35 × 10^-04^
  hsa00350      Tyrosine metabolism                                                3.93 × 10^-04^
  hsa00760      Nicotinate and nicotinamide metabolism                             4.51 × 10^-04^
  hsa00020      Citrate cycle (TCA cycle)                                          0.002
  hsa00190      Oxidative phosphorylation                                          0.002
  hsa00500      Starch and sucrose metabolism                                      0.002
  hsa00280      Valine, leucine and isoleucine degradation                         0.003
  hsa00380      Tryptophan metabolism                                              0.003
  has00720      Reductive carboxylate cycle (CO2 fixation)                         0.007
  hsa00860      Porphyrin and chlorophyll metabolism                               0.019
  hsa00252      Alanine and aspartate metabolism                                   0.032

###### 

Gene ontology categories with significantly decreased expression post-training compared to pre-training levels

  GO ID         GO Term                                                *P*
  ------------- ------------------------------------------------------ ----------------
  BP:0006817    phosphate transport                                    2.92 × 10^-20^
  BP:0015698    inorganic anion transport                              7.84 × 10^-18^
  BP:0050679    positive regulation of epithelial cell proliferation   9.57 × 10^-05^
  CC:0005856    cytoskeleton                                           4.00 × 10^-09^
  CC:0044430    cytoskeletal part                                      5.59 × 10^-09^
  CC:0016528    sarcoplasm                                             6.32 × 10^-07^
  CC:0015629    actin cytoskeleton                                     2.11 × 10^-06^
  CC:0016529    sarcoplasmic reticulum                                 2.93 × 10^-06^
  CC:0005887    integral to plasma membrane                            6.96 × 10^-06^
                                                                       
  **KEGG ID**   **KEGG pathway**                                       ***P***
                                                                       
  hsa04530      Tight junction                                         5.30 × 10^-04^
  hsa04630      Jak-STAT signaling pathway                             0.008
  hsa04720      Long-term potentiation                                 0.013
  hsa01430      Cell communication                                     0.032
  hsa04512      ECM-receptor interaction                               0.046

The most significantly overrepresented cellular compartment GO groups among the genes with increased abundance post-training were mitochondrion (CC GO:0005739; *P*\< 1.04 × 10^-41^) and related terms such as organelle inner membrane (CC GO:0019866) and mitochondrial part (CC GO:0044429). Aerobic respiration (BP GO:0009060), oxidative phosphorylation (BP GO:0006119) and the tricarboxylic acid cycle (GO BP:0006099) were among the overrepresented GO biological processes groups. The KEGG pathways included Citrate cycle (TCA cycle) (hsa00020) and Oxidative phosphorylation (hsa00190) and multiple metabolism pathways. These transcriptional data concur with biochemical and physiological studies that have demonstrated an increase in mitochondrial volume and aerobic capacity following endurance training \[[@B1],[@B2]\]. Although there is evidence to indicate that an increase in oxidative capacity is part of the maturation process in horses \[[@B64]\] it has been demonstrated that exercise training, not growth, causes increases in whole muscle activity of the oxidative enzyme succinate dehydrogynase and changes in muscle fibre type composition in young Thoroughbred horses \[[@B14]\]. To our knowledge, this is the first time that these GO groups have been shown to have increased expression following exercise training.

This highlights the value of using a method such as FatiScan which incorporates all experimental data rather than limiting interpretation to those that rank among the highly differentially expressed. Only three mitochondrial genes were among those significantly differentially expressed: *MRPS21*, *SLC25A29*and *ACADVL*. *MRPS21*is a nuclear-encoded mitochondrial ribosomal gene required for protein synthesis in the mitochondria. Therefore, an increase in mitochondrial abundance would require an increase in mitochondrial protein synthesis. The *SLC25A29*and *ACADVL*proteins are localized in the mitochondrial inner membrane and play a role in fat metabolism \[[@B65],[@B66]\]. The fatty acid oxidation (BP GO:0019395), fatty acid beta-oxidation (BP GO:0006635) and fatty acid metabolic process (BP GO:0006631) GO ontologies were also overrepresented among genes that increased expression following training. This is in agreement with previous observations of a shift towards fatty acid metabolism in response to exercise training \[[@B3]\]. Furthermore, 12 of the 13 up-regulated KEGG pathways were associated with aerobic respiration and metabolism. Overall these results demonstrate that exercise training brings about a subtle but coordinated increase in the basal level of gene expression of a wide array of genes involved in energy production and metabolism.

Interestingly there was also an up-regulation of GO terms involved in the immune response such as the KEGG pathway complement and coagulation cascades, complement activation and positive regulation of immune response. The up-regulation of the complement and coagulation cascades may be a response to exercise induced hemolysis. It has been suggested that exercise induced decreases in blood pH and increases in blood temperature may increase the osmotic fragility of erythrocytes. Previous studies have shown that an immune response is elicited in response to a single bout of exercise and that this response is attenuated in trained subjects. Furthermore, it appears that moderate exercise can enhance the immune response \[[@B67]\], whereas over-training in humans is detrimental to health and can leave athletes more susceptible to infection \[[@B68]\]. Overtraining in horses has been associated with increased levels of the alpha-1-antitrypsin protein \[[@B69]\] which is involved in protection of cells from inflammatory enzymes released from neutrophils \[[@B70]\]. This protein was also found to be increased in humans following a marathon run but returned to basal levels within a few hours \[[@B71]\]. Despite numerous studies documenting the immune response to a single bout of exercise \[[@B72]-[@B74]\], little is known regarding the molecular mechanisms governing the adaptations to the immune response brought about by exercise training. It has been suggested that exercise-induced reactive oxygen species (ROS) may play a major role in the modulation of the immune response following exercise \[[@B75]\]. It is also likely that exercise-induced muscle damage contributes to the inflammatory response \[[@B76]\]. The exercise regime undertaken by the horses in this study incorporated both endurance and sprint work which would be expected to elicit both increased ROS and intramuscular microtears.

Another interesting observation was the increased expression of ribosomal genes as elevated rates of protein synthesis and degradation have been reported following resistance exercise with an overall increase in protein mass \[[@B4],[@B77],[@B78]\].

The down-regulated functional groups were mainly associated with structural genes and ion transport. It has been shown that the cellular response to mechanical stimuli, such as increased load, involves ECM signalling to the cytoskeleton at focal adhesion complexes via integrin receptors. Ion transport is central to muscular contraction. Calcium is the main regulatory and signalling molecule in muscle and ATP synthesis is dependent on phosphate transport. Although the down-regulation of these functional groups is counter-intuitive, the modulation of gene expression in these functional groups may reflect structural reorganization of myofibrils.

Validation of a panel of genes by real time qRT-PCR
---------------------------------------------------

Eleven genes represented by tags that were differentially expressed between untrained and trained skeletal muscle were selected for real time qRT-PCR validation. Four tags (acyl-coenzyme A dehydrogenase, very long chain \[*ACADVL*\], actinin, alpha 3 \[*ACTN3*\], dystroglycan 1 \[*DAG1*\] and 28 S ribosomal protein S21, mitochondrial \[*MRPS21*\]) were located within a known gene and seven (calmodulin 3 \[*CALM3*\], insulin-like growth factor binding protein-5 \[*IGFPB5*\], myostatin \[*MSTN*\], period homolog 2 \[*PER2*\], period homolog 3 \[*PER3*\], solute carrier family 25 member 29 \[*SLC25A29*\] and troponin T type 3 \[*TNNT3*\]) were located within 5 kb of a known gene and were predicted to represent the gene. Primers were designed to span exons 1 and 2 or exons 2 and 3 of the gene of interest. This approach was taken to validate both the differential expression of genes and to assess the prediction that the differentially expressed tags that were identified within 5 kb of a known gene were indeed representative transcripts of that gene.

The mean expression of three of the four genes represented by intergenic tags reached significance (*P*\< 0.05) and concurred with DGE data. *ACTN3*showed the same direction of change as the DGE data and tended towards significance (*P*\< 0.1). The mean expression of six of the seven genes predicted to be represented by adjacent tags agreed with the DGE data, the exception being *TNNT3*. The putative *TNNT3*tag was matched to a region \~880 bp downstream of the *TNNT3*gene and may represent a novel gene or mRNA. Alternatively the tag may span a splice site in an alternative gene and consequently may represent RNA transcribed from a different region in the genome. Real time qRT-PCR results are detailed in Table [7](#T7){ref-type="table"}.

###### 

Real time qRT-PCR results for genes used to validate DGE data

  Tag                 Gene Symbol   Gene Name                                        DGE FC   RT-PCR FC   P
  ------------------- ------------- ------------------------------------------------ -------- ----------- -------
  gctgctctgcagtctga   *ACADVL*      Acyl-Coenzyme A dehydrogenase, very long chain   1.65     1.72        0.014
  acccgagagacagccga   *ACTN3*       Actinin, alpha 3                                 -1.97    -1.41       NS
  ccactaccctcttactc   *CALM3*       Calmodulin 3                                     -2.75    -1.81       0.028
  gaaaacagtagctaaag   *DAG1*        Dystroglycan 1                                   -2.81    -1.27       0.021
  ggactgtctttattttt   *IGFBP5*      Insulin-like growth factor binding protein-5     -4.35    -3.18       0.023
  gagtgcagcctttcacc   *MRPS21*      28 S ribosomal protein S21, mitochondrial        9.47     6.03        0.013
  tatgacagaaaagcaac   *MSTN*        Myostatin                                        -4.35    -4.97       0.004
  tgttgaagcgatgcagt   *PER2*        Period homolog 2                                 +inf     1.88        0.003
  tgttggtaagtagatcg   *PER3*        Period homolog 3 (Drosophila)                    2.07     1.74        0.001
  tggctgtatggggaggc   *SLC25A29*    Solute carrier family 25 member 29               2.50     1.22        0.035
  gatgaagctgggatgca   *TNNT3*       Troponin T Type 3                                2.93     0.94        NS

The figure for the DGE fold change could not be calculated due to the fact that the PER2 transcript was undetectable pre-training (the transcript had zero counts in all the pre-training samples).

The *PER2*and *PER3*genes, key molecular clock components within the mammalian circadian timing system \[[@B79]\], had mean post-training increases in expression of +1.88-fold and +1.74 fold respectively. The induction of these genes may represent an entrainment of the muscle transcriptional clock by a regular exercise regime. While primarily regulated by photoperiodic signals to the master pacemaker within the suprachiasmatic nucleus, peripheral circadian clocks, which are known to exist in almost all peripheral tissues examined to date \[[@B80]\], can also be entrained by alternative timing cues including exercise \[[@B81]\] and feeding \[[@B82]\]. The role of peripheral clocks is to align specific tissue function to the correct time of day via differential regulation of subsets of clock-controlled genes.

As exercise is a known synchroniser of circadian rhythms in mice \[[@B83]\], humans \[[@B81]\] and horses \[[@B84]\], and *PER2*has previously been shown to oscillate in equine tissues \[[@B85]\], the increased expression of PER genes post-training in the current study is thought to represent a strengthening of the endogenous circadian clock in equine muscle. Furthermore, human studies have shown time of day variations in exercise performance at the physiological level \[[@B86]-[@B88]\], and it has been suggested that circadian rhythms may play an important role in sports performance \[[@B89]\]. Combined with our results, this is strong incentive for further investigation of the influence of training times on daily muscle function in the horse, such that optimal athletic performance may be achieved.

The proteins encoded by *ACADVL*(+1.72-fold, *P*= 0.014), *MRPS21*(+6.03-fold, *P*= 0.013) and *SLC25A29*(+1.22-fold, *P*= 0.350) function in the mitochondria to increase protein synthesis and fat metabolism. The increase in expression of the gene encoding the mitochondrial ribosomal protein MRPS21 likely reflects an increase in mitochondrial protein synthesis and an overall increase in mitochondrial volume. Numerous studies have demonstrated an increase in mitochondrial volume concurrent with an increase in VO~2max~following endurance training \[[@B90]-[@B93]\]. The proteins encoded by *ACADVL*and *SLC25A29*are involved in fat metabolism and are located in the mitochondrial inner membrane.

*ACTN3*, *CALM3*and *DAG1*were decreased in expression by -1.41-fold (*P*= 0.090), -1.81-fold (P = 0.028) and -1.27-fold (*P*= 0.021) respectively. The ACTN3 protein is localized to the skeletal muscle z-discs and DAG1 forms part of the dystroglycan complex. A null mutation in the *ACTN3*gene has been associated with sprint performance in human athletes \[[@B94]\] and *DAG1*has been proposed as a candidate gene in some muscular myopathies \[[@B95],[@B96]\]. CALM3 is an isoform of calmodulin, a calcium-modulated protein which regulate numerous protein targets. The binding of calcium to calmodulin induces a conformational change which affects its ability to bind target proteins. In this manner calmodulin may be used by other proteins as a calcium sensor and signal transducer. CALM3 may be involved in muscle fibre type transformation in response to muscle excitation \[[@B97],[@B98]\]. *CALM3*gene expression was also decreased in equine muscle four hours post exhaustive treadmill exercise \[[@B47]\].

*IGFBP5*and *MSTN*encode growth factors with large observed decreases in expression post training (-3.18-fold, *P*= 0.023 and -4.97-fold *P*= 0.004 respectively). IGFBP5 is one of family of modulators of insulin like growth factors (IGFs) which interact with IGFs resulting in an increase in half life and alteration of the interaction with receptors. IGF-1 promotes muscle hypertrophy and protein levels are increased in humans following administration of human growth hormone as an illegal doping agent \[[@B99],[@B100]\]. The exact mode of action of IGFBP5 is poorly understood however it has been shown to associate with the extra cellular matrix and is a regulator of a wide range of physiological processes including cell proliferation and muscle cell differentiation \[[@B101]-[@B103]\].

Myostatin encoded by the *MSTN*gene is a negative regulator of muscle growth and an inhibitor of satellite cell proliferation\[[@B104]\]. The expression of *MSTN*was found to be decreased in humans following resistance training \[[@B105],[@B106]\]. Null mutations in this gene have been found to cause a double muscling phenotype in cattle, dogs, and humans \[[@B107]-[@B111]\]. Structural variation in the *MSTN*gene has also been associated with athletic performance in dogs \[[@B110]\] and horses \[[@B112]\]. The differential expression of this gene is of particular significance as an intronic SNP in equine *MSTN*has been found to be a strong predictor of optimal racing distance in Thoroughbred racehorses \[[@B112]\].

Conclusion
==========

Deep sequencing of the equine skeletal muscle transcriptome has revealed novel transcripts and functional groups associated with this tissue. Furthermore, following exercise training we have observed an increase in the occurrence of genes involved in metabolism and oxidative phosphorylation, and a decrease in the expression of structural genes. Overrepresented functional groups of genes post-training were associated with both endurance and resistance exercise. This study documents the transcriptome-wide reprogramming of skeletal muscle in Thoroughbred racehorses that brings about the well documented phenotypic adaptations to exercise.

Methods
=======

Subjects
--------

All animal procedures were approved by the University College Dublin, Animal Research Ethics Committee, a licence was granted from the Department of Health and Children (Ireland) and owners\' consent was obtained for all horses.

Seven two-year-old untrained Thoroughbred horses (*n*= 5 females, *n*= 2 entire males), raised on the same farm for the previous 2 - 3 months and destined for Flat racing with the same trainer comprised the study cohort. The horses had a mean height of 154.9 cm (± 2.8) and a mean pre-training weight of 437.4 kg (± 18.0). All horses undertook a regular exercise regime with the same trainer for 10 months (trained). This consisted of light canter (1,500 m) once a day six times a week on an all-weather gallop and higher intensity exercise (\"work\") no more than once a week which consisted of warm-up (walk and trot) followed by gallop with velocities reaching maximal intensity for 800-1,000 m.

Muscle biopsy sampling
----------------------

Percutaneous needle muscle biopsies \[[@B113]\] were obtained from the dorsal compartment of the *gluteus medius*muscle according to Dingboom and colleagues \[[@B114]\] using a 6 mm diameter, modified Bergstrom biopsy needle (Jørgen KRUUSE, Veterinary Supplies). Biopsies were taken approximately 15 cm caudodorsal (one-third of the distance) to the *tuber coxae*on an imaginary line drawn from the *tuber coxae*to the head of the tail. The biopsies were obtained at a depth of 80 mm. Each biopsy site was shaved, scrubbed with an antiseptic and desensitized by a local anaesthetic. The biopsy samples were washed with sterile PBS (BD Biosciences, San Jose, CA) and preserved in RNA*later*(Ambion, UK) for 24 hours at 4°C and then stored at -20°C. Muscle biopsy samples were collected at rest at two time points: T~0~-untrained and T~2~-trained.

RNA isolation and purification
------------------------------

Approximately 100 mg of each muscle biopsy sample was removed from RNA*later*and homogenized in 1 ml TRIzol using a TissueLyser (Qiagen Ltd, Crawley, UK) and extracted according to the manufacturer\'s instructions. Each sample was purified using the RNeasy^®^Mini kit (Qiagen Ltd, Crawley, UK) and DNase treated with RNase free DNase (Qiagen Ltd, Crawley, UK). RNA was quantified using a NanoDrop^®^ND1000 spectrophotometer V 3.5.2 (NanoDrop Technologies, Wilmington, DE) and RNA quality was subsequently assessed using the 18S/28 S ratio and RNA integrity number (RIN) on an Agilent Bioanalyser with the RNA 6000 Nano LabChip kit (Agilent Technologies Ireland Ltd, Dublin, Ireland) according to the manufacturers\' instructions.

Library preparation for Illumina sequencing
-------------------------------------------

The Illumina cDNA library was prepared according to the manufacturer\'s instructions. All reagents were supplied by Illumina apart from SuperScript II Reverse Transcriptase (part \# 18064-014) with 100 mM DTT. Briefly, 1.5 μg mRNA was isolated from total RNA by binding the mRNA to a magnetic oligo(dT) bead. Double stranded cDNA was synthesized and cleaved at each *Nla*III site. The site of *Nla*III cleavage was ligated with an Illumina-supplied adaptor using T4 DNA ligase. The bead bound double stranded cDNA was the cut by the restriction enzyme, *Mme*I. This resulted in a 17 bp tag which was no longer attached to the oligo(dT) bead. The cDNA construct was then precipitated and the site of *Mme*I cleavage was ligated with an Illumina-supplied adaptor using T4 DNA ligase. The adaptor ligated cDNA was PCR amplified with two adapter primers (Illumina). The PCR product of 85 bp was purified by gel extraction in preparation for loading on the Illumina Cluster Station. The quality and quantity of the purified constructs were assessed using an Agilent DNA series 7500 series II assay (Agilent Technologies Ireland Ltd, Dublin, Ireland) and Qubit fluorometer according to manufacturer\'s instructions. Cluster generation and sequencing analysis were carried out using Illumina\'s Solexa Sequencer according to the manufacturer\'s instructions.

Analysis
--------

The DGE samples were processed through the standard software pipeline provided by Illumina for the Genome Analyzer. The sequence reads were base called using the Bustard base caller (part of the Illumina software). The tag annotation pipeline consisted of two parts: mapping to known Ensembl \[[@B115]\] cDNAs and mapping to the genome. The known cDNAs from version 49 of Ensembl for the EquCab2 assembly of the equine genome were downloaded in FASTA format using the Ensembl biomart tool. The FASTA files for the individual equine chromosomes were downloaded from the UCSC genome browser website \[[@B116]\]. A pipeline consisting of perl, C++ and linux shell scripts was used to conduct an *in-silico*digestion of both the transcriptome and genome and to generate tag location records which were loaded into a MySQL database. The tag records were then annotated according to their type (genomic or cDNA, canonical, noncanonical, repeat etc.). A matrix of tag counts for each sample was generated. The edgeR Bioconductor package \[[@B117]\] was used to determine differential expression of tags in each group.

Functional clustering according to gene ontology annotations
------------------------------------------------------------

The equine Ensembl gene IDs were cross-matched to human Ensembl gene IDs. Using the Ensembl IDs of human homologues of equine genes it was possible to use the Database for Annotation, Visualization and Integrated Discovery (DAVID) \[[@B118],[@B119]\] for functional clustering and overrepresentation analyses. The Expression Analysis Systematic Explorer (EASE) tool \[[@B120]\] within DAVID was used to investigate the representation of functional groups in equine skeletal muscle relative to the whole genome. The FatiScan \[[@B121],[@B122]\] gene enrichment test was used to analyse the transcriptional profile post-training. FatiScan is part of the Babelomics Suite of web tools and tests for the asymmetrical distribution of biological labels in an ordered list of genes through application of a Fisher\'s exact test. Genes were ranked by differential expression and FatiScan was used to detect functional blocks (GO and KEGG pathways) that were significantly up-regulated and down-regulated post-training. Results from both EASE and FatiScan were corrected for multiple testing using the Benjamini and Hochberg method \[[@B123]\].

Real time quantitative RT-PCR
-----------------------------

Selected cDNA samples were quantified by real time quantitative RT-PCR (qRT-PCR). 1 μg of total RNA from each sample was reverse transcribed into cDNA with oligo-dT primers using a SuperScript™ III first strand synthesis SuperMix kit according to the manufacturer\'s instructions (Invitrogen Ltd, Paisley, UK). The converted cDNA was diluted to 2.5 ng/μl working stocks and stored at -20°C for subsequent analyses. Oligonucleotide primers for real time qRT-PCR were designed using Primer3 version 3.0 <http://www.primer3.sourceforge.net> and commercially synthesized (MWG Biotech, Germany). Primer details are shown in Table [8](#T8){ref-type="table"}. Each reaction was carried out in a total volume of 20 μl with 5 μl of cDNA (1 ng/μl), 10 μl SYBR^®^Green PCR Master Mix (Applied Biosystems, Cambridgeshire, UK) and 5 μl primer/H~2~O. Real time qRT-PCR was performed using a 7500 Fast Real-Time PCR machine (Applied Biosystems, Cambridgeshire, UK). All reactions were performed in duplicate. Hypoxanthine phosphoribosyltransferase 1 (*HPRT*) was selected as a stable reference gene based on a study of equine reference genes for real time qRT-PCR \[[@B124]\] and on the DGE results. Expression values were calculated using a standard curve which was plotted based on the expression of *HPRT*in serial dilutions of equine skeletal muscle RNA (1:1, 1:2, 1:4, 1:8, 1:16, 1:32, and 1:64). The standard curve method was used to normalise the gene expression data. The paired Student\'s t-test was used to identify significant differences in mRNA abundance between time-points.

###### 

Real time qRT-PCR primers for genes used to validate DGE data

  Gene symbol   Forward Primer             Reverse Primer
  ------------- -------------------------- --------------------------
  *ACADVL*      ctgcccagcgatcctatg         ttccactggtcgaagtctca
  *ACTN3*       cggcgagtatatggaacagg       gtgagttgcaccaggcagt
  *CALM*        agcacttggtggactccttg       aaatgcctgactgtgctcaa
  *DAG1*        ccaggaggagtgagcacct        ctcaccctctgcacacctg
  *IGFBP5*      ggaggagccgagaacactg        gcgaagcctccatgtgtc
  *MRPS21*      ggagatctgctgtttgctca       tctctcaaagcgacccatct
  *MSTN*        tgacagcagtgatggctctt       ttgggttttccttccacttg
  *PER2*        agcctgatgatggcgaagtctgaa   agttctttgtgcgtgtctgccttg
  *PER3*        aactatgcccttcgctgtgt       gtacccggtcacatctgctt
  *SLC25A29*    ggacacccgtttgacactg        ctgatgatggattggaagca
  *TNNT3*       cggagggggagaaagtagac       caaagtggctgtcgatgaga
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